Anti‐cancer function of phytic acid

International Journal of Food Science and Technology - Tập 37 Số 7 - Trang 769-782 - 2002
Abulkalam M. Shamsuddin1
1Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201‐1192, USA

Tóm tắt

Summary Inositol hexaphosphate (InsP6 a.k.a. phytic acid or IP6) is ubiquitous. In the plant kingdom it is particularly abundant in cereals and legumes; in much smaller amounts IP6 and its lower phosphorylated forms (IP1−5) are contained in most mammalian cells, where they are important in regulating vital cellular functions. Both in vivo and in vitro experiments have demonstrated striking anticancer (preventive as well as therapeutic) effects of IP6. Inositol also is anti‐carcinogenic, albeit to a lesser extent; it acts synergistically IP6 in inhibiting cancer. In addition to reduction in cell proliferation, IP6 increases differentiation of malignant cells often resulting in reversion to the normal phenotype. IP6 is quickly absorbed from the rat stomach and upper intestine and distributed as inositol and IP1. In vitro, it is instantaneously taken up by malignant cells undergoing variable dephosphorylation to inositol and IP1−5, pointing towards their role in mediating the action of IP6. In humans, IP6 has recently been detected in urine, plasma and other biological fluids; the levels fluctuating with ingestion or deprivation of IP6 or IP6‐rich diet. As IP6 is high in high‐fibre diets, these also may explain, at least in part, the epidemiological observation showing the association of ingesting high‐fibre diets with a lower incidence of certain cancers. Along with safety, the reproducible efficacy of IP6 and inositol in the prevention of cancer in laboratory animals warrant their inclusion in our strategies for cancer prevention and perhaps therapy in humans. Aside from the anticancer action, IP6 and inositol also have numerous other health benefits. All these facts of normal physiological presence of IP6 in our body the level of which fluctuates with intake, association of an IP6‐rich diet with low incidence of several diseases and vice versa, and finally reversal of some of these conditions, at least in part, by IP6 supplementation strongly argue in favour of its inclusion as an essential nutrient or perhaps a vitamin.

Từ khóa


Tài liệu tham khảo

10.1016/0304-3835(93)90254-7

10.1016/S0008-6215(96)00250-9

10.1093/carcin/10.9.1595

Borgo E.(1983).Sodium phytate formulations inhibiting platelet aggregation.French Patent2515042.

10.1002/mc.1048

10.1079/BJN19500025

10.1016/0167-4889(91)90091-B

El‐Sherbiny Y.M., 2001, G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6), Anticancer Research, 21, 2393

10.1080/01635588209513738

10.1093/carcin/14.9.1975

10.1016/0891-5849(90)90146-A

10.1080/003655998750015412

10.1080/003655900750016526

10.1002/biof.5520150105

10.1016/S0955-2863(01)00178-4

Grases F. Simonet B.M. Vucenik I. Perelló J. Prieto R.M.&Shamsuddin A.M.(2002).Effects of exogenous inositol hexaphosphate (InsP6) on inositol triphosphate (InsP3) and InsP6in malignant cells tissues and biological fluids.Life Sciences in press.

10.1016/S0092-8674(00)00061-1

10.1159/000415199

10.1016/S0304-3835(98)00326-7

10.1056/NEJM195810232591702

10.1146/annurev.nu.06.070186.003023

Huang C., 1997, Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol‐3′ kinase, Cancer Research, 57, 2873

Ishikawa T., 1999, Inhibition of skin cancer by IP6 in vivo: initiation‐promotion model, Anticancer Research, 19, 3749

10.1016/S0271-5317(88)80161-1

Jariwalla R.J., 1990, Lowering of serum cholesterol and triglycerides and modulations by dietary phytate, Journal of Applied Nutrition, 42, 18

Johnson M., 2000, The effects of inositol hexaphosphate on the inflammatory response in transformed RAW 264.7 macrophages, Biomedical Scientific Instrumentation, 36, 21

Kelsay J.L., 1987, Effects of fiber, phytic acid, and oxalic acid in the diet on mineral bioavailability, American Journal of Gastroenterology, 82, 983

Lambertenghi‐Deliliers G., 2002, Effect of inositol hexaphosphate (IP6) on human normal and leukemic hematopoietic cells, British Journal of Haematology, 117, 1

10.1126/science.278.5337.471

10.1016/S0924-977X(97)00409-4

10.1074/jbc.C200030200

10.1016/0968-0004(93)90053-P

Morales M., 1992, Breast cancer and diet in Spain, Journal of Environmental Pathology, Toxicology and Oncology, 11, 157

10.1126/science.8342038

10.1016/S0022-5347(17)50065-8

Otake T., 1989, Inhibitory effect of inositol hexasulfate and inositol hexaphosphoric acid (phytic acid) on the proliferation of the human immunodeficiency virus (HIV) in vitro [Japanese], Kansenshogaku Zasshi, Journal of the Japanese Association of Infectious Diseases, 63, 676

10.1016/0003-4975(91)91254-S

10.1093/carcin/14.9.1815

10.1093/jn/123.4.713

Shamsuddin A.M.(1992).Reduction of cell proliferation and enhancement of NK‐cell activity.US Patent5 082 833.

10.1093/carcin/10.3.625

10.1093/carcin/9.4.577

10.1093/carcin/10.8.1461

10.1016/0304-3835(92)90043-U

10.1016/0006-291X(87)90489-X

10.1093/carcin/12.11.2041

10.1093/carcin/11.12.2219

Vucenik I., 1994, [3H]‐inositol hexaphosphate (phytic acid) is rapidly absorbed and metabolized by murine and human malignant cells in vitro, Journal of Nutrition, 124, 861, 10.1093/jn/124.6.861

10.1016/0304-3835(92)90206-B

10.1016/0304-3835(93)90193-D

10.1093/carcin/16.5.1055

10.1080/01635589709514546

Vucenik I., 1998, Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo, Anticancer Research, 18, 1377

Vucenik I., 1998, IP6 in treatment of liver cancer I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line, Anticancer Research, 18, 4083

Vucenik I., 1998, IP6 in treatment of liver cancer II. Intra‐tumoral injection of IP6 regresses pre‐existing human liver cancer xenotransplanted in nude mice, Anticancer Research, 18, 4091

Vucenik I., 1999, Inositol hexaphosphate (IP6) differentially modulates the expression of PKC* in MCF‐7 and MDA‐MB 231 cells, Proceedings of the American Association for Cancer Research, 40, 653

Vucenik I., 1999, Antiplatelet activity of inositol hexaphosphate (IP6), Anticancer Research, 19, 3689

10.1042/bj0420452

Wattenberg L.W., 1996, Chemopreventive effects of myo‐inositol and dexamethasone on benzo[a]pyrene and 4‐(methylnitrosoamino)‐1‐(3‐pyridyl)‐1‐butanone‐induced pulmonary carcinogenesis in female A/J mice, Cancer Research, 56, 5132

10.1126/science.8160011

Yang G.‐Y., 1995, IP6‐induced growth inhibition and differentiation of HT‐29 human colon cancer cells: involvement of intracellular inositol phosphates, Anticancer Research, 15, 2479

10.1126/science.285.5424.96

10.1093/ije/20.1.76

Zang E.A., 1994, Differences in nutritional risk factors for breast cancer among New York City White, Hispanic, and Black college students, Ethnicity and Disease, 4, 28

10.1093/carcin/21.12.2225

Thông tin
Thông tin xuất bản

International Journal of Food Science and Technology

Tập 37 Số 7

769-782

Thông tin tác giả